InvestorsHub Logo
Followers 145
Posts 27561
Boards Moderated 3
Alias Born 02/07/2004

Re: None

Thursday, 04/16/2020 8:20:06 AM

Thursday, April 16, 2020 8:20:06 AM

Post# of 41
One other company i recommend looking
into is BVXV.

A short description of the company:

About BiondVax

BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) is Phase 3 clinical phase bio pharmaceutical company developing the M-001 Universal Flu Vaccine. M-001 is currently undergoing a pivotal, clinical efficacy, Phase 3 trial in about 12,400 participants. Results of the clinical trial are expected by the end of 2020.

M-001 is designed to provide multi-season and multi-strain protection against all human influenza virus strains, both seasonal and pandemic. In 7 completed clinical trials the vaccine was shown to be safe, well tolerated and immunologic to a broad range of flu strains.

More at http://www.biondvax.com/

Disclosure: I own some 270 shares.

Since you are into bios, i think that this one has great
potential. Can you imagine the potential of a universal flu vaccine?

Influenza is not a hot subject nowadays, Corona took all
limelight, but its day will come - hopefully



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SLGL News